668 related articles for article (PubMed ID: 26809472)
1. Circulating tumor cells in breast cancer.
Bidard FC; Proudhon C; Pierga JY
Mol Oncol; 2016 Mar; 10(3):418-30. PubMed ID: 26809472
[TBL] [Abstract][Full Text] [Related]
2. Markers of circulating breast cancer cells.
López-Muñoz E; Méndez-Montes M
Adv Clin Chem; 2013; 61():175-224. PubMed ID: 24015603
[TBL] [Abstract][Full Text] [Related]
3. Relevance of CTC Clusters in Breast Cancer Metastasis.
Piñeiro R; Martínez-Pena I; López-López R
Adv Exp Med Biol; 2020; 1220():93-115. PubMed ID: 32304082
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells in breast cancer: detection systems, molecular characterization, and future challenges.
Lianidou ES; Markou A
Clin Chem; 2011 Sep; 57(9):1242-55. PubMed ID: 21784769
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057
[TBL] [Abstract][Full Text] [Related]
6. Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.
Kujur PK; Flores BCT; Ramalingam N; Chinen LTD; Jeffrey SS
Adv Exp Med Biol; 2020; 1220():61-80. PubMed ID: 32304080
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients.
Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME
Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316
[TBL] [Abstract][Full Text] [Related]
8. Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancer.
Smerage JB; Budd GT; Doyle GV; Brown M; Paoletti C; Muniz M; Miller MC; Repollet MI; Chianese DA; Connelly MC; Terstappen LW; Hayes DF
Mol Oncol; 2013 Jun; 7(3):680-92. PubMed ID: 23538216
[TBL] [Abstract][Full Text] [Related]
9. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
[TBL] [Abstract][Full Text] [Related]
10. Clinical Applications of Circulating Tumor Cells in Breast Cancer.
Cobain EF; Paoletti C; Smerage JB; Hayes DF
Recent Results Cancer Res; 2020; 215():147-160. PubMed ID: 31605228
[TBL] [Abstract][Full Text] [Related]
11. Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.
Vismara M; Reduzzi C; Daidone MG; Cappelletti V
Adv Exp Med Biol; 2020; 1220():81-91. PubMed ID: 32304081
[TBL] [Abstract][Full Text] [Related]
12. Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer.
Lianidou ES; Mavroudis D; Georgoulias V
Br J Cancer; 2013 Jun; 108(12):2426-32. PubMed ID: 23756869
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.
Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L
BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845
[TBL] [Abstract][Full Text] [Related]
14. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor Cells.
Paoletti C; Hayes DF
Adv Exp Med Biol; 2016; 882():235-58. PubMed ID: 26987538
[TBL] [Abstract][Full Text] [Related]
16. Disseminated tumor cells in bone marrow and circulating tumor cells in blood of breast cancer patients: current state of detection and characterization.
Riethdorf S; Pantel K
Pathobiology; 2008; 75(2):140-8. PubMed ID: 18544969
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of women with stage IV breast cancer depends on detection of circulating tumor cells rather than disseminated tumor cells.
Bidard FC; Vincent-Salomon A; Sigal-Zafrani B; Diéras V; Mathiot C; Mignot L; Thiery JP; Sastre-Garau X; Pierga JY
Ann Oncol; 2008 Mar; 19(3):496-500. PubMed ID: 18187488
[TBL] [Abstract][Full Text] [Related]
18. Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: the observational step of the CirCe01 phase III trial.
Helissey C; Berger F; Cottu P; Diéras V; Mignot L; Servois V; Bouleuc C; Asselain B; Pelissier S; Vaucher I; Pierga JY; Bidard FC
Cancer Lett; 2015 May; 360(2):213-8. PubMed ID: 25700777
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial.
Gennari A; Foca F; Zamarchi R; Rocca A; Amadori D; De Censi A; Bologna A; Cavanna L; Gianni L; Scaltriti L; Rossi E; Facchinetti A; Martini V; Bruzzi P; Nanni O
Breast Cancer Res Treat; 2020 May; 181(1):61-68. PubMed ID: 32200486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]